Corman VM, Eickmann M, Landt O, Bleicker T, Brünink S, Eschbach-Bludau M, Matrosovich M, Becker S, Drosten C. Specific detection by real-time reverse-transcription PCR assays of a novel avian influenza A(H7N9) strain associated with human spillover infections in China. (2013). Euro Surveill. 18;18(16):20461.
Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, Wack A. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. (2013). PLoS Pathog. 9(11):e1003773.
Crusat M, Liu J, Palma AS, Childs RA, Liu Y, Wharton SA, Lin YP, Coombs PJ, Martin SR, Matrosovich M, Chen Z, Stevens DJ, Hien VM, Thanh TT, Nhu le NT, Nguyet LA, Ha do Q, van Doorn HR, Hien TT, Conradt HS, Kiso M, Gamblin SJ, Chai W, Skehel JJ, Hay AJ, Farrar J, de Jong MD, Feizi T. Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding. (2013). Virology. 447(1-2):326-37.
Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, Dattilo BM, Denisova EA, De Souza I, Eickmann M, Dugan VG, Ferrari A, Gomila RC, Han L, Judge C, Mane S, Matrosovich M, Merryman C, Palladino G, Palmer GA, Spencer T, Strecker T, Trusheim H, Uhlendorff J, Wen Y, Yee AC, Zaveri J, Zhou B, Becker S, Donabedian A, Mason PW, Glass JI, Rappuoli R, Venter JC. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. (2013). Sci Transl Med. 15;5(185):185ra68.Dürrwald R, Schlegel M, Bauer K, Vissiennon T, Wutzler P, Schmidtke M. Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs. (2013). PLOS One. 8(4):e61597.Ehrhardt C, Rückle A, Hrincius ER, Haasbach E, Anhlan D, Ahmann K, Banning C, Reiling SJ, Kühn J, Strobl S, Vitt D, Leban J, Planz O, Ludwig S. The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance. (2013). Cell Microbiol. Jul;15(7):1198-211.Ehrhardt, C., Dudek, S. E., Holzberg, M., Urban, S., Hrincius, E. R., Haasbach, E., Seyer, R., Lapuse, J., Planz, O., and Ludwig, S.A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells. (2013). PLoS ONE. 8:e63657.Feld, M., Shpacovitch, V., Ehrhardt, C., Fastrich, M., Goerge, T., Ludwig, S., and Steinhoff, M. Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ-induced antiviral pathways in human neutrophils. (2013). BioMed Research International 2013, 879080.Friesenhagen J, Viemann D, Boergeling Y, Schmolke M, Spiekermann C, Kirschnek S, Ludwig S, Roth J. Highly pathogenic influenza viruses inibit inflammatory response in monocytes via activation of Rar-related orphan receptor RORα. (2013). J Innate Immun.5(5):505-18.Glück B, Schmidtke M, Walther M, Meerbach A, Wutzler P. Simvastatin treatment showed no prophylactic effect in influenza virus-infected mice. (2013). J Med Virol. 85(11):1978-82.
Grienke U, Braun H, Seidel N, Kirchmair J, Richter M, Krumbholz A, von Grafenstein S, Liedl KR, Schmidtke M, Rollinger JM. Computer-Guided Approach to Access the Anti-influenza Activity of Licorice Constituents. (2013). J Nat Prod. Dec 6. [Epub ahead of print].
Haasbach E, Hartmayer C, Planz O. Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro. (2013). Antiviral Res. 98(2):319-24.
Haasbach, E., Reiling, S. J., Ehrhardt, C., Droebner, K., Rückle, A., Hrincius, E. R., Leban, J., Strobl, S., Vitt, D., Ludwig, S., and Planz, O. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. (2013). Antiviral Research. 99:336-344.
Hatesuer B, Bertram S, Mehnert N, Bahgat MM, Nelson PS, Pöhlman S, Schughart K. Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice. (2013). PLoS Pathog. 9(12):e1003774. Hoegner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, Walmrath HD, Bodner J, Gattenloehner S, Lewe-Schlosser P, Matrosovich M, Seeger W, Lohmeyer J, Herold S. Macrophage-expressed IFN-β mediates apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. (2013). PLOS Pathog. Feb;9(2):e1003188.Hoffmann M, Müller MA, Drexler JF, Glende J, Erdt M, Gützkow T, Deng H, Schwegmann- Weßels C, Esser K-H, Drosten C, Herrler G. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. (2013). PLOS One. Aug 30;8(8):e72942. Kallfass C, Lienenklaus S, Weiss S, Staeheli P. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. (2013). J Virol. 87(12):6925-30. Kaminski MM, Ohnemus A, Staeheli P, Rubbenstroth D. Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model. (2013). J. Virol. 87:1912-1915.Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B. PAR1 contributes to influenza A virus pathogenicity in mice. (2013). J Clin Invest. 123(1):206-14.Knepper J, Schierhorn KL, Becher A, Budt M, Tönnies M, Bauer TT, Schneider P, Neudecker J, Rückert JC, Gruber AD, Suttorp N, Schweiger B, Hippenstiel S, Hocke AC, Wolff T. The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. (2013). MBio. 8;4(5):e00601-13.
Knuschke T, Sokolova V, Rotan O, Wadwa M, Tenbusch M, Hansen W, Staeheli P, Epple M, Buer J, Westendorf AM. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. (2013). J Immunol. 15;190(12):6221-9.
Kolesnikova L, Heck S, Matrosovich T, Klenk HD, Becker S, Matrosovich M. Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells. (2013). J Gen Virol. 94(Pt 5):971-6.
Krumbholz A, Lange J, Dürrwald R, Walther M, Müller TH, Kühnel D, Wutzler P, Sauerbrei A, Zell R. Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. (2013). Med Microbiol Immunol. Sep 8. [Epub ahead of print].
Lange J, Groth M, Schlegel M, Krumbholz A, Wieczorek K, Ulrich R, Köppen S, Schulz K, Appl D, Selbitz HJ, Sauerbrei A, Platzer M, Zell R, Dürrwald R. Reassortants of the pandemic (H1N1) 2009 virus and establishment of a novel porcine H1N2 influenza virus, lineage in Germany. (2013). Vet Microbiol. 27;167(3-4):345-56. Loeffler, B., Niemann, S., Ehrhardt, C., Horn, D., Lanckohr, C., Lina, G., Ludwig, S., and Peters, G. Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. (2013). Expert review of anti-infective therapy. 11: 1041-1051. (Review).
Lohrmann F, Dijkman R, Stertz S, Thiel V, Haller O, Staeheli P, Kochs G. Emergence of a C-terminal seven-amino-acid elongation of NS1 in around 1950 conferred a minor growth advantage to former seasonal influenza A viruses. (2013). J Virol. 87(20):11300-3.
Mänz B, Dornfeld D, Götz V, Zell R, Zimmermann P, Haller O, Kochs G, Schwemmle M. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. (2013). PLOS Pathog. Mar;9(3):e1003279.Mänz B, Schwemmle M, Brunotte L. Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. (2013). J Virol. 87(13):7200-9.
Matrosovich M, Herrler G, Klenk HD. Sialic Acid Receptors of Viruses. (2013). Top Curr Chem. Jul 20. [Epub ahead of print].
Matthaei M, Budt M, Wolff T. Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells. (2013). PLoS One. 8(2):e56659.
Meng F, Punyadarsaniya D, Uhlenbruck S, Hennig-Pauka I, Schwegmann-Wessels C, Ren X, Dürrwald R, Herrler G. Replication characteristics of swine influenza viruses in precision-cut lung slices reflect the virulence properties of the viruses. (2013). Vet Res. 13;44(1):110. Mostafa A, Kanrai P, Ziebuhr J, Pleschka S. Improved dual promotor-driven reverse genetics system for influenza viruses. (2013). J Virol Methods. Nov;193(2):603-10.Petersen H, Wang Z, Lenz E, Pleschka S, Rautenschlein S. Reassortment of NS Segments Modifies Highly Pathogenic Avian Influenza Virus Interaction with Avian Hosts and Host Cells. (2013). J Virol. May;87(10):5362-71.Planz O. Development of cellular signaling pathway inhibitors as new antivirals against influenza. (2013). Antiviral Res. 98(3):457-68. Review.Pleschka S. Overview of Influenza Viruses. (2013). Curr Top Microbiol Immunol. 370:1-20.Preusse M, Tantawy MA, Klawonn F, Schughart K, Pessler F. Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice. (2013). BMC Microbiol. 17;13:293. Sauer A-K, Liang C-H, Stech J, Peeters B, Quéré P, Schwegmann-Wessels C, Wu C-Y, Chi- Huey Wong C-H, Herrler G. Characterization of the sialic acid binding activity of the hemagglutinins of the H7 and H9 subtypes by using soluble proteins as lectins. Submitted.Skovgaard K, Cirera S, Vasby D, Podolska A, Breum SØ, Dürrwald R, Schlegel M, Heegaard PM. Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2). (2013). Innate Immun. 19(5):531-44. Teske L, Ryll M, Rautenschlein S. Epidemiological investigations on the role of clinically healthy racing pigeons as a reservoir for avian paramyxovirus-1 and avian influenza virus. (2013). Avian Pathol. Dec;42(6):557-65. Van Poucke S, Uhlendorff J, Wang Z, Billiau V, Nicholls J, Matrosovich M, Van Reeth K. Effect of receptor specificity of A/Hong Kong/1/68 (H3N2) influenza virus variants on replication and transmission in pigs. (2013). Influenza Other Respi Viruses. 7(2):151-9.von Grafenstein S, Wallnoefer HG, Kirchmair J, Fuchs JE, Huber RG, Schmidtke M, Sauerbrei A, Rollinger JM, Liedl KR. Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity. (2013). J Biomol Struct Dyn. Nov 27. [Epub ahead of print].Wedde M, Wählisch S, Wolff T, Schweiger B. Predominance of HA-222D/G polymorphism in influenza A(H1N1)pdm09 viruses associated with fatal and severe outcomes recently circulating in Germany. (2013). PLoS One. 8(2):e57059.
Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. (2013). J Virol. 87(23):13053-8. Zell R, Scholtissek C, Ludwig S.Genetics, evolution and the zoonotic capacity of European swine influenza viruses. (2013). Curr Top Microbiol Immunol. 370:29-55.
Crotta S, Davidson S, Mahlakoiv T, Desmet CJ, Buckwalter MR, Albert ML, Staeheli P, Wack A. Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia. (2013). PLoS Pathog. 9(11):e1003773.
Crusat M, Liu J, Palma AS, Childs RA, Liu Y, Wharton SA, Lin YP, Coombs PJ, Martin SR, Matrosovich M, Chen Z, Stevens DJ, Hien VM, Thanh TT, Nhu le NT, Nguyet LA, Ha do Q, van Doorn HR, Hien TT, Conradt HS, Kiso M, Gamblin SJ, Chai W, Skehel JJ, Hay AJ, Farrar J, de Jong MD, Feizi T. Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding. (2013). Virology. 447(1-2):326-37.
Dormitzer PR, Suphaphiphat P, Gibson DG, Wentworth DE, Stockwell TB, Algire MA, Alperovich N, Barro M, Brown DM, Craig S, Dattilo BM, Denisova EA, De Souza I, Eickmann M, Dugan VG, Ferrari A, Gomila RC, Han L, Judge C, Mane S, Matrosovich M, Merryman C, Palladino G, Palmer GA, Spencer T, Strecker T, Trusheim H, Uhlendorff J, Wen Y, Yee AC, Zaveri J, Zhou B, Becker S, Donabedian A, Mason PW, Glass JI, Rappuoli R, Venter JC. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. (2013). Sci Transl Med. 15;5(185):185ra68.Dürrwald R, Schlegel M, Bauer K, Vissiennon T, Wutzler P, Schmidtke M. Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs. (2013). PLOS One. 8(4):e61597.Ehrhardt C, Rückle A, Hrincius ER, Haasbach E, Anhlan D, Ahmann K, Banning C, Reiling SJ, Kühn J, Strobl S, Vitt D, Leban J, Planz O, Ludwig S. The NF-κB inhibitor SC75741 efficiently blocks influenza virus propagation and confers a high barrier for development of viral resistance. (2013). Cell Microbiol. Jul;15(7):1198-211.Ehrhardt, C., Dudek, S. E., Holzberg, M., Urban, S., Hrincius, E. R., Haasbach, E., Seyer, R., Lapuse, J., Planz, O., and Ludwig, S.A Plant Extract of Ribes nigrum folium Possesses Anti-Influenza Virus Activity In Vitro and In Vivo by Preventing Virus Entry to Host Cells. (2013). PLoS ONE. 8:e63657.Feld, M., Shpacovitch, V., Ehrhardt, C., Fastrich, M., Goerge, T., Ludwig, S., and Steinhoff, M. Proteinase-activated receptor-2 agonist activates anti-influenza mechanisms and modulates IFNγ-induced antiviral pathways in human neutrophils. (2013). BioMed Research International 2013, 879080.Friesenhagen J, Viemann D, Boergeling Y, Schmolke M, Spiekermann C, Kirschnek S, Ludwig S, Roth J. Highly pathogenic influenza viruses inibit inflammatory response in monocytes via activation of Rar-related orphan receptor RORα. (2013). J Innate Immun.5(5):505-18.Glück B, Schmidtke M, Walther M, Meerbach A, Wutzler P. Simvastatin treatment showed no prophylactic effect in influenza virus-infected mice. (2013). J Med Virol. 85(11):1978-82.
Grienke U, Braun H, Seidel N, Kirchmair J, Richter M, Krumbholz A, von Grafenstein S, Liedl KR, Schmidtke M, Rollinger JM. Computer-Guided Approach to Access the Anti-influenza Activity of Licorice Constituents. (2013). J Nat Prod. Dec 6. [Epub ahead of print].
Haasbach E, Hartmayer C, Planz O. Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro. (2013). Antiviral Res. 98(2):319-24.
Haasbach, E., Reiling, S. J., Ehrhardt, C., Droebner, K., Rückle, A., Hrincius, E. R., Leban, J., Strobl, S., Vitt, D., Ludwig, S., and Planz, O. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. (2013). Antiviral Research. 99:336-344.
Hatesuer B, Bertram S, Mehnert N, Bahgat MM, Nelson PS, Pöhlman S, Schughart K. Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice. (2013). PLoS Pathog. 9(12):e1003774. Hoegner K, Wolff T, Pleschka S, Plog S, Gruber AD, Kalinke U, Walmrath HD, Bodner J, Gattenloehner S, Lewe-Schlosser P, Matrosovich M, Seeger W, Lohmeyer J, Herold S. Macrophage-expressed IFN-β mediates apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. (2013). PLOS Pathog. Feb;9(2):e1003188.Hoffmann M, Müller MA, Drexler JF, Glende J, Erdt M, Gützkow T, Deng H, Schwegmann- Weßels C, Esser K-H, Drosten C, Herrler G. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. (2013). PLOS One. Aug 30;8(8):e72942. Kallfass C, Lienenklaus S, Weiss S, Staeheli P. Visualizing the beta interferon response in mice during infection with influenza A viruses expressing or lacking nonstructural protein 1. (2013). J Virol. 87(12):6925-30. Kaminski MM, Ohnemus A, Staeheli P, Rubbenstroth D. Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model. (2013). J. Virol. 87:1912-1915.Khoufache K, Berri F, Nacken W, Vogel AB, Delenne M, Camerer E, Coughlin SR, Carmeliet P, Lina B, Rimmelzwaan GF, Planz O, Ludwig S, Riteau B. PAR1 contributes to influenza A virus pathogenicity in mice. (2013). J Clin Invest. 123(1):206-14.Knepper J, Schierhorn KL, Becher A, Budt M, Tönnies M, Bauer TT, Schneider P, Neudecker J, Rückert JC, Gruber AD, Suttorp N, Schweiger B, Hippenstiel S, Hocke AC, Wolff T. The novel human influenza A(H7N9) virus is naturally adapted to efficient growth in human lung tissue. (2013). MBio. 8;4(5):e00601-13.
Knuschke T, Sokolova V, Rotan O, Wadwa M, Tenbusch M, Hansen W, Staeheli P, Epple M, Buer J, Westendorf AM. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. (2013). J Immunol. 15;190(12):6221-9.
Kolesnikova L, Heck S, Matrosovich T, Klenk HD, Becker S, Matrosovich M. Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells. (2013). J Gen Virol. 94(Pt 5):971-6.
Krumbholz A, Lange J, Dürrwald R, Walther M, Müller TH, Kühnel D, Wutzler P, Sauerbrei A, Zell R. Prevalence of antibodies to European porcine influenza viruses in humans living in high pig density areas of Germany. (2013). Med Microbiol Immunol. Sep 8. [Epub ahead of print].
Lange J, Groth M, Schlegel M, Krumbholz A, Wieczorek K, Ulrich R, Köppen S, Schulz K, Appl D, Selbitz HJ, Sauerbrei A, Platzer M, Zell R, Dürrwald R. Reassortants of the pandemic (H1N1) 2009 virus and establishment of a novel porcine H1N2 influenza virus, lineage in Germany. (2013). Vet Microbiol. 27;167(3-4):345-56. Loeffler, B., Niemann, S., Ehrhardt, C., Horn, D., Lanckohr, C., Lina, G., Ludwig, S., and Peters, G. Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfection. (2013). Expert review of anti-infective therapy. 11: 1041-1051. (Review).
Lohrmann F, Dijkman R, Stertz S, Thiel V, Haller O, Staeheli P, Kochs G. Emergence of a C-terminal seven-amino-acid elongation of NS1 in around 1950 conferred a minor growth advantage to former seasonal influenza A viruses. (2013). J Virol. 87(20):11300-3.
Mänz B, Dornfeld D, Götz V, Zell R, Zimmermann P, Haller O, Kochs G, Schwemmle M. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. (2013). PLOS Pathog. Mar;9(3):e1003279.Mänz B, Schwemmle M, Brunotte L. Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. (2013). J Virol. 87(13):7200-9.
Matrosovich M, Herrler G, Klenk HD. Sialic Acid Receptors of Viruses. (2013). Top Curr Chem. Jul 20. [Epub ahead of print].
Matthaei M, Budt M, Wolff T. Highly pathogenic H5N1 influenza A virus strains provoke heterogeneous IFN-α/β responses that distinctively affect viral propagation in human cells. (2013). PLoS One. 8(2):e56659.
Meng F, Punyadarsaniya D, Uhlenbruck S, Hennig-Pauka I, Schwegmann-Wessels C, Ren X, Dürrwald R, Herrler G. Replication characteristics of swine influenza viruses in precision-cut lung slices reflect the virulence properties of the viruses. (2013). Vet Res. 13;44(1):110. Mostafa A, Kanrai P, Ziebuhr J, Pleschka S. Improved dual promotor-driven reverse genetics system for influenza viruses. (2013). J Virol Methods. Nov;193(2):603-10.Petersen H, Wang Z, Lenz E, Pleschka S, Rautenschlein S. Reassortment of NS Segments Modifies Highly Pathogenic Avian Influenza Virus Interaction with Avian Hosts and Host Cells. (2013). J Virol. May;87(10):5362-71.Planz O. Development of cellular signaling pathway inhibitors as new antivirals against influenza. (2013). Antiviral Res. 98(3):457-68. Review.Pleschka S. Overview of Influenza Viruses. (2013). Curr Top Microbiol Immunol. 370:1-20.Preusse M, Tantawy MA, Klawonn F, Schughart K, Pessler F. Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice. (2013). BMC Microbiol. 17;13:293. Sauer A-K, Liang C-H, Stech J, Peeters B, Quéré P, Schwegmann-Wessels C, Wu C-Y, Chi- Huey Wong C-H, Herrler G. Characterization of the sialic acid binding activity of the hemagglutinins of the H7 and H9 subtypes by using soluble proteins as lectins. Submitted.Skovgaard K, Cirera S, Vasby D, Podolska A, Breum SØ, Dürrwald R, Schlegel M, Heegaard PM. Expression of innate immune genes, proteins and microRNAs in lung tissue of pigs infected experimentally with influenza virus (H1N2). (2013). Innate Immun. 19(5):531-44. Teske L, Ryll M, Rautenschlein S. Epidemiological investigations on the role of clinically healthy racing pigeons as a reservoir for avian paramyxovirus-1 and avian influenza virus. (2013). Avian Pathol. Dec;42(6):557-65. Van Poucke S, Uhlendorff J, Wang Z, Billiau V, Nicholls J, Matrosovich M, Van Reeth K. Effect of receptor specificity of A/Hong Kong/1/68 (H3N2) influenza virus variants on replication and transmission in pigs. (2013). Influenza Other Respi Viruses. 7(2):151-9.von Grafenstein S, Wallnoefer HG, Kirchmair J, Fuchs JE, Huber RG, Schmidtke M, Sauerbrei A, Rollinger JM, Liedl KR. Interface dynamics explain assembly dependency of influenza neuraminidase catalytic activity. (2013). J Biomol Struct Dyn. Nov 27. [Epub ahead of print].Wedde M, Wählisch S, Wolff T, Schweiger B. Predominance of HA-222D/G polymorphism in influenza A(H1N1)pdm09 viruses associated with fatal and severe outcomes recently circulating in Germany. (2013). PLoS One. 8(2):e57059.
Xiao H, Killip MJ, Staeheli P, Randall RE, Jackson D. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. (2013). J Virol. 87(23):13053-8. Zell R, Scholtissek C, Ludwig S.Genetics, evolution and the zoonotic capacity of European swine influenza viruses. (2013). Curr Top Microbiol Immunol. 370:29-55.